_____________________________________________________________________________Revista Cientifica, FCV-LUZ / Vol. XXXIV, rcfcv-e34418
5 of 6
basis, milk is an extremely valuable source of income for breeders.
According to the information we received from the breeders during
our study, it was determined that they did not look forward to the
destruction of milk as it caused a serious loss of income in previous
treatment attempts.
In the light of this information, in this study carried out in Muş and
its region, where Morkaraman and Akkaraman sheep breeds are
common, a treatment comparison was made between the preparation
with Cefquinome active ingredient that does not pass into milk and
the preparation with Tilmicosin which leaves residue in milk and meat
for a long time so that the breeders use the milk with peace of mind
and do not have to waste the milk.
It has been determined that both antibiotics are strong in terms of
therapeutic ecacy and there is no signicant difference between
them. This is in line with the report by Venning et al. [10] and Winter
[11] that systemic antibiotics do not differ in the recovery of the
disease. In addition, in terms of treatment success it was observed
that both drugs cured the disease by 90-95% after the 6
th
d, and the
success rates increased further in the following days. This situation is
also consistent with the above-mentioned literature data on systemic
antibiotics [4, 24, 25, 26, 27, 28, 29, 30].
In the market conditions of 2021, it is seen that the same dose of
Cefquinome preparations are sold at the same price as Tilmicosin
preparations or 20-30% more. As stated in the materials and methods
section for drug use and dosage, Tilmicosin will be practically calculated
according to 1ml/30kg body weight and a maximum of two applications
can be made due to drug toxicity, and for Cefquinome, 3-5 applications
can be made corresponding to 1 mL·50 kg
-1
body weight. In our study,
three applications were sucient because over 90% treatment success
was achieved after the third application of Cefquinome. The average
live weight of the sheep included in the study groups was 50-55 kg, a
total of 124 mL of Cefquinome was applied to the S-Group, and a total
of 136 mL of Tilmicosin was applied to the T-Group. Therefore, since
both drugs are very close to each other in terms of consumption and
cost, there is no need to make an evaluation on this issue.
CONCLUSION
In conclusion, when planning treatment in animals raised for food
purposes, rational drug selection should be made, taking into account
the risk of drug residue. On this occasion, when the drug containing
the active ingredient Cefquinome is used in the treatment of footrot
disease with antibiotics, the success rate exceeds 90% after the
4
th
d, it is capable of treating the disease in a short time with three
applications, it does not require additional costs, it can be easily
obtained by growers and it can be used easily in eld conditions. It
has been evaluated that it can be preferred by breeders as it does
not pass into milk and does not pose a risk of residue and milk is not
wasted. Thus, it was concluded that it should be recommended for
both animal health and welfare, food safety and public health.
Financial support
This study was supported with the project code TSA-2020-8176 by
the Presidency of Van YYU Scientic Research Project.
Conict of interest
The authors declare that there are no conicts of interest.
BIBLIOGRAPHIC REFERENCES
[1] Sağlıyan A, Güney C, Koparır M. [The Role of Copper and Zinc
in the Etiology of Footrot of Sheep in Elazığ Region]. Vet. Cer.
Derg. 2003; 9(1-2):11-16. Turkish.
[2] Sertkaya H, Şındak N. [Incidence and treatment with two different
drug combinations of sheep’ s footrot in Birecik district of Şanlıurfa
and its villages]. Vet. Cer. Derg. 2004; 10(1-2):48-54. Turkish
[3] Sulu K, Alkan F. [Footrot]. Bahri Dağdaş Hayvancılık Araştırma
Dergisi. [Internet]. 2018 [cited 12 Feb 2024]; 7(1):18-32. Turkish.
Available in: https://goo.su/W0UML
[4] Yıldız F, Gençcelep M. [Comparative Studies on the Treatment and
Incidence of Footrot in Sheep in Muş and its Region]. Van. Vet. J.
[Internet]. 2021; 32(1):33-42. Turkish. https://doi.org/m84f
[5] Green L, Kaler J, Wassink G, King E, Grogono-Thomas R. Impact
of rapid treatment of sheep lame with footrot on welfare and
economics and farmer attitudes to lameness in sheep. Anim.
Welf. [Internet]. 2012; 21(S1):65-71. https://doi.org/f3zh2q
[6] Lovatt F. Causes, control and costs of lameness in sheep. Vet.
Irel. J. [Internet]. 2015 [cited 12 Jan 2024]; 5(4):189-192. Available
in: https://goo.su/1ZVnow
[7] Wassink GJ, King EM, Grogono-Thomas R, Brown JC, Moore LJ,
Green LE. A within farm clinical trial to compare two treatments
(parenteral antibacterials and hoof trimming) for sheep lame
with footrot. Prev. Vet. Med. [Internet]. 2010; 96(1-2):93–103.
https://doi.org/bx8z3v
[8] Abbott KA, Lewis CJ. Current approaches to the management of
ovine footrot. Vet. J. [Internet]. 2005; 169(1):28-41. doi: https://
doi.org/bcsw9s
[9] Grogono-Thomas R, Wilsmore AJ, Simon AJ, Izzard KA. The use
of long-action oxytetracycline for the treatment of ovine footrot.
Br. Vet. J. [Internet]. 1994; 150(6):561-568. https://doi.org/gf8f7j
[10] Venning CM, Curtis MA, Egerton JR. Treatment of virulent footrot
with lincomycin and spectinomycin. Aust. Vet. J. [Internet].
1990; 67(7):258-260. https://doi.org/cmb32k
[11] Winter A. Lameness in sheep. Small. Rum. Res. [Internet]. 2008;
76(1-2):149-153. https://doi.org/bbnk67
[12] Alkan F. [Foot diseases in sheep and general approach]. In:
3rd Sheep Goat Health and Management Congress; 27-29 Apr
2017; Bursa (Türkiye): Farm Animal Medicine Association; 2017.
p 23-32. Turkish.
[13] Greber D, Bearth G, Lüchinger R, Schüpbach-Regula G, Steiner A.
Elimination of virulent strains (aprV2) of Dichelobacter nodosus
from feet of 28 Swiss sheep ocks: a proof of concept study.
Vet. J. [Internet]. 2016; 216:25-32. https://doi.org/f87qw5
[14] O’Neill J. Tackling drug-resistant ınfections globally: Final report
and recommendations. The review on antimicrobial resistance
[Internet]. London: Government of the United Kingdom; 2016
[cited 05 Feb 2024]; 84 p. Available in: https://goo.su/RTnHz
[15] European Centre for Disease Prevention and Control. Guidelines
for the prudent use of antimicrobials in veterinary medicine. Off.
J. Eur. Union [Internet]. 2015 [cited 18 Feb 2024]; 26 p. Available
in: https://goo.su/inGyzP